ERDC - Eosinophilic & Rare Disease Cooperative

ERDC - Eosinophilic & Rare Disease Cooperative ERDC develops & distributes Hospital & Emergency kits for patients & loved ones with rare diseases.

09/20/2025
Medicare Part B Infusion Proposed Changes & Medicare Prior Authorization PilotsMedicare (CMS) is proposing changes that ...
09/19/2025

Medicare Part B Infusion Proposed Changes & Medicare Prior Authorization Pilots

Medicare (CMS) is proposing changes that could significantly affect access to infusion medications as well as new pilot programs requiring prior authorization, which may delay or restrict treatment.

This livestream will help us all learn about the proposed changes and what we can do about them.
To register go to: https://luma.com/6h88rg8y

If you were not able to join Dr. Jessica Most, pulmonologist and medical director of eosinophilic disorders at AstraZene...
07/07/2025

If you were not able to join Dr. Jessica Most, pulmonologist and medical director of eosinophilic disorders at AstraZeneca, this interactive educational livestream is worth your time!

Yesterday, I had the honor of representing ERDC - Eosinophilic & Rare Disease Cooperative and the broader rare disease c...
06/04/2025

Yesterday, I had the honor of representing ERDC - Eosinophilic & Rare Disease Cooperative and the broader rare disease community at a standing-room-only Congressional briefing on tariffs and their impact on the healthcare supply chain. Over 70 attendees—mostly legislative staff—joined to better understand what’s at stake.

💡 Did you know it takes 24 individual medical items to safely deliver a single infusion? Now, Congressional staff do too—thanks to this important conversation.

Millions of Americans with chronic and rare conditions rely on timely access to infusions, devices, and treatments. Tariffs on pharmaceuticals and medical supplies threaten to delay care, disrupt treatment, and harm lives. This is preventable—and action is needed.

Grateful to Center Forward for the invitation and to my fellow panelists from Biotech Innovation Organization (Hilary Stiss), National Association of Manufacturers - NAM, and Healthcare Supply Chain Association for an engaging and urgent dialogue.

This issue affects all of us—patients, providers, manufacturers, and lawmakers alike. Let’s keep the pressure on to ensure healthcare remains accessible, uninterrupted, and affordable.

We’re feeling the good kind of tired after a powerful   — energized by community, connection, and impact.But let’s be cl...
05/31/2025

We’re feeling the good kind of tired after a powerful — energized by community, connection, and impact.

But let’s be clear:
Being tired is not the same as disease-related fatigue.
Vasculitis-related fatigue is relentless and debilitating — it’s a symptom, not just exhaustion.

Let’s keep raising awareness. Keep educating. Keep fighting.

Ever leave the doctor’s office thinking, “I wish I’d said more”?You’re not alone—and now’s your chance to say it. 💥We’re...
05/30/2025

Ever leave the doctor’s office thinking, “I wish I’d said more”?
You’re not alone—and now’s your chance to say it. 💥

We’re collecting anonymous insights for “What Your Patients Don’t Tell You”—to be shared directly with rheumatologists at their national conference. Let them hear the truth.
📢 Take the survey →https://s.surveyplanet.com/e8w28u68


Looking for trusted info on   and ANCA-associated conditions? The new ANCA Resource Hub by Amgen  has you covered—educat...
05/29/2025

Looking for trusted info on and ANCA-associated conditions? The new ANCA Resource Hub by Amgen has you covered—education, tools, and real support all in one place.

💥 Bonus: Grab your FREE while you’re there!

Check it out 👉 https://www.anca101.com/

✨ Curious about EGPA? This rare form of   can seriously impact the body—and without treatment, the damage can be permane...
05/28/2025

✨ Curious about EGPA? This rare form of can seriously impact the body—and without treatment, the damage can be permanent.

ERDC - Eosinophilic & Rare Disease Cooperative is shining a light on this often-overlooked and sending major kudos to AstraZeneca for stepping up with a new treatment last fall! 🙌

Learn more + spread awareness: https://www.fasenra.com/egpa/what-is-egpa

Let's broaden awareness about   and the impact it has on people with  . It is silent, but it hurts and destroys organs -...
05/26/2025

Let's broaden awareness about and the impact it has on people with . It is silent, but it hurts and destroys organs - permanently!
Follow us ERDC - Eosinophilic & Rare Disease Cooperative and stay engaged!

Vasculitis isn’t just inflammation — it can cause serious organ damage.Without treatment, 80% of people with EGPA won’t ...
05/25/2025

Vasculitis isn’t just inflammation — it can cause serious organ damage.
Without treatment, 80% of people with EGPA won’t survive beyond 5 years. Early diagnosis and the right can make all the difference.

Vasculitis is serious, systemic, and life-threatening — no matter the type.
Speak up. Get support. Don’t wait.

Vasculitis cannot be treated with diet alone.An anti-inflammatory diet might support overall health — but it does NOT st...
05/24/2025

Vasculitis cannot be treated with diet alone.
An anti-inflammatory diet might support overall health — but it does NOT stop this disease.
Spreading misinformation can be dangerous, even deadly.

This , let’s set the record straight.
Early diagnosis and medical treatment are essential.

Address

Tucson, AZ
85757

Alerts

Be the first to know and let us send you an email when ERDC - Eosinophilic & Rare Disease Cooperative posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ERDC - Eosinophilic & Rare Disease Cooperative:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram